HKSE - Delayed Quote HKD
Keymed Biosciences Inc. (2162.HK)
48.200
-1.400
(-2.82%)
As of 1:01:49 PM GMT+8. Market Open.
Major Holders
| Breakdown | |
|---|---|
| 32.62% | % of Shares Held by All Insider |
| 30.26% | % of Shares Held by Institutions |
| 44.91% | % of Float Held by Institutions |
| 82 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 1.99M | Oct 31, 2022 | 0.71% | 95,691,027 |
| iShares Core MSCI Emerging Markets ETF | 1.19M | Nov 30, 2022 | 0.42% | 57,285,700 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 506.5k | Oct 31, 2022 | 0.18% | 24,413,300 |
| Avantis Emerging Markets Equity ETF | 203.5k | Dec 31, 2022 | 0.07% | 9,808,700 |
| iShares Core MSCI Total International Stock ETF | 164.5k | Nov 30, 2022 | 0.06% | 7,928,900 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 128k | Sep 30, 2022 | 0.05% | 6,169,600 |
| iShares MSCI China Small Cap ETF | 112.5k | Nov 30, 2022 | 0.04% | 5,422,500 |
| SPDR Portfolio Emerging Markets ETF | 97.5k | Sep 30, 2022 | 0.03% | 4,699,500 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF | 60k | Nov 30, 2022 | 0.02% | 2,892,000 |
| Avantis Emerging Markets Value ETF | 53.5k | Dec 31, 2022 | 0.02% | 2,578,700 |
Related Tickers
688488.SS Jiangsu Aidea Pharmaceutical Co., Ltd.
15.03
+7.05%
688222.SS HitGen Inc.
17.43
+0.98%
688180.SS Shanghai Junshi Biosciences Co., Ltd.
34.62
+2.21%
2487.HK Cutia Therapeutics
11.460
+2.50%
2256.HK Abbisko Cayman Limited
10.380
0.00%
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
79.950
+3.63%
2410.HK TYK Medicines, Inc
23.400
-0.64%
6955.HK Shandong Boan Biotechnology Co., Ltd.
13.180
+7.33%
1877.HK JUNSHI BIO
22.850
+1.11%
1873.HK VIVA BIOTECH
1.830
+0.55%